The acquisition is centered on Dark Blue Therapeutics' small-molecule degrader of the MLLT1 and MLLT3 proteins, which is ...

The updated second edition delivers expanded insights into solid-state pharmaceutical materials, reflecting major scientific ...

Low levels of albumin, a protein found in blood, are associated with poor clinical outcomes for people with the fungal ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Cradle provides a scientific AI software platform focused on protein engineeringBayer continues to utilize AI in R&D, ...

Despite the Great Salt Lake's dire straits, state researchers and elected leaders remain optimistic that Utah will become the ...

Hour Fitness today announced that company founder and fitness industry trailblazer Mark Mastrov is returning as Owner and Executive Chair to accelerate the brand into its next phase of innovation and ...

Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), of $3.3 million with further ...

The GLP-1 market is primed for substantial growth due to rising obesity and diabetes rates. Opportunities lie in expanding drug applications beyond diabetes, focusing on weight management in ...

Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...

Last year, sales of obesity treatments surpassed Keytruda, the immune anticancer drug that had long held the top sales ...

Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- HUTCHME ...